ARQL

ArQule, Inc. News Headlines

$1.88
*  
0.09
4.57%
Get ARQL Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading ARQL now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARQL After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
ArQule To Present At RBC Capital Markets Conference; Webcast At 9:00 AM ET
2/24/2015 8:00:00 AM - RTT News


ArQule To Present At Leerink Healthcare Conference ; Webcast At 8:00 AM ET
2/11/2015 7:01:00 AM - RTT News


ARIAD & Angelini Team Up to Commercialize Iclusig in Europe - Analyst Blog
12/31/2014 2:35:00 PM - Investopedia


A Close Look At ArQule
2/8/2014 3:20:00 PM - Seeking Alpha


5 Speculative Biotech Stocks With Catalysts Pending: Revisited
7/17/2013 11:58:00 AM - Seeking Alpha


Early-Stage Clinical Data Highlights From AACR 2013
4/17/2013 7:07:00 AM - Seeking Alpha


These 4 Biotech Stocks Have Upside, Says Burrill's Senior Analyst
3/25/2013 4:02:00 PM - Seeking Alpha


George Zavoico: Biotech Stocks That Deserve A Closer Look
3/8/2013 3:15:00 AM - Seeking Alpha


5 Speculative Biotech Stocks With Catalysts Pending
2/25/2013 9:50:00 AM - Seeking Alpha


Latest Tivantinib Failure Hits ArQule Despite Its Irrelevance
1/15/2013 5:40:00 AM - Seeking Alpha


Thursday's Small Cap Biotech Catalyst Watch List
1/3/2013 8:30:00 AM - Seeking Alpha


Biotech Portfolio Update: 2012 Summary And 2013 Outlook
12/24/2012 7:24:00 AM - Seeking Alpha


ArQule: A Strong Speculation BioPharma Poised For A Quick Move Up On Near Term Catalyst
12/19/2012 8:00:00 AM - Seeking Alpha


Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration
12/18/2012 7:55:00 AM - Seeking Alpha


ArQule: An Inexpensive And Well-Financed Oncology Opportunity
12/13/2012 1:57:00 PM - Seeking Alpha


ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
10/12/2012 9:10:00 AM - Seeking Alpha


Weekend Recap: Biotech Madness
10/6/2012 4:13:00 PM - Seeking Alpha


As ArQule Investors Panic, Watch Exelixis Too
10/3/2012 8:19:00 AM - Seeking Alpha


7 Innovative Biotechs That Could Soar By Year-End: George Zavoico
9/13/2012 4:00:00 PM - Seeking Alpha


Should Seattle Genetics Start Thinking More Like A Pharma Company?
3/14/2012 5:42:00 PM - Seeking Alpha


Arqule's Strategy Continues To Generate Value
1/23/2012 10:05:00 AM - Seeking Alpha


Pfizer's Xalkori: The Story Can Only Get Better
11/28/2011 12:25:00 PM - Seeking Alpha


Small Cap Biotech: Top Buy And Sell Ideas Based On Last Week's Big News, Price Movers
9/19/2011 1:32:00 AM - Seeking Alpha


Drugs to Watch at ASCO 2011
6/2/2011 8:32:00 AM - Seeking Alpha


3 Biotechs With Momentum Ahead of ASCO
4/4/2011 11:24:00 AM - Seeking Alpha